# A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma

> **NCT02004210** · PHASE3 · WITHDRAWN · sponsor: **Seoul National University Hospital**

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** transarterial radioembolization (TARE)
- **PROCEDURE:** transarterial chemoembolization (TACE)

## Key facts

- **NCT ID:** NCT02004210
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants were enrolled.
- **Last updated:** 2016-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004210, "A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02004210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*